Physician profile
Robert C Richman
NPI 1013997626
$3,970.76
in general payments reported to CMS, 2019-2025
20 companies · $950 in 2025
The $950 reported for 2025 was more than what 79% of Medical providers received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $437 · 2022: $864 · 2023: $988 · 2024: $732 · 2025: $950.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,670.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,669.72 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $1,052.98 | 2021-2025 | Proclaim, Eterna, Octrode |
| Medtronic, INC. | $1,043.27 | 2021-2025 | Intellis Adaptivestim, Inceptiv |
| Boston Scientific Corporation | $699.01 | 2023-2025 | Wavewriter Alpha Prime 16, General - Pain Management |
| Abbvie INC. | $487.51 | 2021-2025 | |
| Pfizer INC. | $118.97 | 2023-2024 | |
| Collegium Pharmaceutical, INC. | $115.04 | 2022-2024 | Xtampza |
| Biohaven Pharmaceuticals, INC. | $103.51 | 2021 | |
| Biohaven Pharmaceutical Holding Company LTD. | $63.47 | 2022 | |
| Amneal Pharmaceuticals LLC | $43.12 | 2023 | Lyvispah |
| Vertex Pharmaceuticals Incorporated | $43.09 | 2024-2025 | |
| International Rehabilitative Sciences, INC | $30.48 | 2023 | Rs 4i Plus Sequential Stimulator |
| Ibsa Pharma INC. | $28.75 | 2022-2025 | Tirosint, Flector, Licart |
| Relievant Medsystems, INC. | $26.05 | 2023 | Intracept |
| Averitas Pharma INC. | $20.41 | 2024 | Qutenza |
| Tonix Medicines, INC. | $20.35 | 2025 | Tonmya |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $17.31 | 2025 | Zepbound |
| Lundbeck LLC | $17.22 | 2022 | |
| Vertos Medical, INC. | $16.93 | 2023 | Mild Device Kit |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $14.68 | 2022 | |
| Spr Therapeutics, INC | $8.61 | 2024 | Sprint Pns System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Richman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.